Business
Research Reports Initiated on Healthcare Stocks Oncolytics Biotech, BELLUS Health, Emerald Health Therapeutics, and OrganiGram Holdings
LONDON, UK / ACCESSWIRE / February 27, 2017 / Active Wall St. announces the list of stocks f...
About this update from Organigram Global Inc.
[{"type":"text","content":"Research Reports Initiated on Healthcare Stocks Oncolytics Biotech, BELLUS Health, Emerald Health Therapeutics, and OrganiGram HoldingsLONDON, UK / ACCESSWIRE / February 27, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Biotechnology industry. Companies recently under review include Oncolytics Biotech, BELLUS Health, Emerald Health Therapeutics, and OrganiGram Holdings. Get all of our free research reports by signing up at:\nhttp://www.activewallst.com/register/\nOn Friday, February 24, 2017, the Toronto Exchange Composite Index was down 1.57%, finishing the day at 15,533.47. The TSX Venture Composite Index, on the other hand, closed at 836.27, down 0.38%.\nThe Healthcare Index was also in the red, closing the day at 74.08, down 2.31%.\nActive Wall St. has initiated research reports on the following equities: Oncolytics Biotech Inc. (TSX: ONC), BELLUS Health Inc. (TSX: BLU), Emerald Health Therapeutics Inc. (TSX-V: EMH), and OrganiGram Holdings Inc. (TSX-V: OGI). Register with us now for your free membership and research reports at:\nhttp://www.activewallst.com/register/\nOncolytics Biotech Inc.\nCalgary, Canada headquartered Oncolytics Biotech Inc.'s stock fell 5.13%, to finish Friday's session at $0.37 with a total volume of 203,121 shares traded. Over the last one month and the previous three months, Oncolytics Biotech's shares have surged 37.04% and 68.18%, respectively. Shares of the Company, which focuses on the discovery and development of pharmaceutical products for the treatment of cancers, are trading above its 50-day and 200-day moving averages. See our research report on ONC.TO at:\nhttp://www.activewallst.com/register/\nBELLUS Health Inc.\nOn Friday, shares in Laval, Canada-based BELLUS Health Inc. recorded a trading volume of 261,020 shares, which was higher than their three months average volume of 55,040 shares. The stock ended the day 3.85% lower at $0.25. BELLUS Health's stock has advanced 4.17% in the past three months. Shares of the Company, which together with its subsidiaries, focuses on the research and development of drugs for rare diseases, are trading below its 50-day moving average of $0.27. The complimentary research r...